Neuroprotective effects of resveratrol in an MPTP mouse model of Parkinson's-like disease: possible role of SOCS-1 in reducing pro-inflammatory responses.
Lofrumento, Dario D
Neuroprotective effects of resveratrol in an MPTP mouse model of Parkinson's-like disease: possible role of SOCS-1 in reducing pro-inflammatory responses. [electronic resource] - Innate immunity Apr 2014 - 249-60 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1753-4267
10.1177/1753425913488429 doi
Animals
Cytokines--biosynthesis
Dopaminergic Neurons--drug effects
Immunohistochemistry
Inflammation--drug therapy
MPTP Poisoning--drug therapy
Macrophage Activation--drug effects
Male
Mice
Mice, Inbred C57BL
Neostriatum--metabolism
Neuroglia--drug effects
Neuroprotective Agents--therapeutic use
Real-Time Polymerase Chain Reaction
Resveratrol
Stilbenes--therapeutic use
Substantia Nigra--metabolism
Suppressor of Cytokine Signaling 1 Protein
Suppressor of Cytokine Signaling Proteins--biosynthesis
Tyrosine 3-Monooxygenase--metabolism
Up-Regulation--drug effects
Neuroprotective effects of resveratrol in an MPTP mouse model of Parkinson's-like disease: possible role of SOCS-1 in reducing pro-inflammatory responses. [electronic resource] - Innate immunity Apr 2014 - 249-60 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1753-4267
10.1177/1753425913488429 doi
Animals
Cytokines--biosynthesis
Dopaminergic Neurons--drug effects
Immunohistochemistry
Inflammation--drug therapy
MPTP Poisoning--drug therapy
Macrophage Activation--drug effects
Male
Mice
Mice, Inbred C57BL
Neostriatum--metabolism
Neuroglia--drug effects
Neuroprotective Agents--therapeutic use
Real-Time Polymerase Chain Reaction
Resveratrol
Stilbenes--therapeutic use
Substantia Nigra--metabolism
Suppressor of Cytokine Signaling 1 Protein
Suppressor of Cytokine Signaling Proteins--biosynthesis
Tyrosine 3-Monooxygenase--metabolism
Up-Regulation--drug effects